Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with almost no curative chemotherapeutic treatment. Besides the development of new compounds, repurposing of approved drugs to treat cancer, alone or in combination, has become an attractive strategy, showing many therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Can, Lan, Wenjun, Fraunhoffer, Nicolas, Meilerman, Analía, Iovanna, Juan, Santofimia-Castaño, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966621/
https://www.ncbi.nlm.nih.gov/pubmed/31769431
http://dx.doi.org/10.3390/cancers11121869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966621/
https://www.ncbi.nlm.nih.gov/pubmed/31769431
http://dx.doi.org/10.3390/cancers11121869

Ejemplares similares